Education and Work Experience May 2022 – Present: Administrative Deputy Director of the Department of Bone Oncology, The First Affiliated Hospital of Sun Yat-sen University Dec. 2020 – Present: Chief Physician, Department of Bone Oncology, The First Affiliated Hospital of Sun Yat-sen University Jan. 2016 – Dec. 2020: Associate Chief Physician, Department of Bone Oncology, The First Affiliated Hospital of Sun Yat-sen University Mar. 2010 – Mar. 2011: Postdoctoral Fellow at MD Anderson Cancer Center, the top-ranked cancer center in the United States Sep. 2000 – Jul. 2011: Completed undergraduate, master’s and doctoral studies at Sun Yat-sen University 2012 – 2018: He was successively awarded titles and supported by programs including Outstanding Young Medical Talent of Guangdong Province, Young Faculty Training Program of Sun Yat-sen University, Outstanding Young Talent Support Program of The First Affiliated Hospital of Sun Yat-sen University, and Distinguished Young Doctor of the Strongest Clinical Specialty Program of Guangdong Hospitals.

Research Interests Limb-salvage surgery and minimally invasive surgery for bone and soft tissue tumors, and treatment of pulmonary metastasis. His research focuses on novel individualized limb-salvage procedures, precision therapy, targeted therapy, immunotherapy and multidisciplinary comprehensive management.

Clinical Expertise: (1) He has extensive experience in limb salvage and comprehensive treatment of bone and soft tissue tumors. He specializes in limb-salvage surgery for benign and malignant bone and soft tissue tumors of the extremities, expandable prosthesis limb salvage for pediatric bone tumors, individualized biological reconstruction, articular surface-preserving and physis-preserving procedures, and minimally invasive surgery for benign pediatric bone tumors. (2) Wide resection of pelvic and sacral bone and soft tissue tumors with individualized prosthesis reconstruction, en bloc resection and reconstruction of spinal tumors, reconstruction with 3D‑printed prostheses and minimally invasive treatment. (3) He has conducted in-depth research on cutting-edge fields including precise diagnosis, minimally invasive treatment, immunotherapy, targeted therapy and multidisciplinary management of metastatic tumors in the spine, extremities and pelvis. (4) Common diseases for diagnosis and treatment include: malignant bone tumors such as osteosarcoma, Ewing sarcoma, chondrosarcoma, chordoma and undifferentiated pleomorphic sarcoma; intermediate-type bone tumors such as giant cell tumor of bone, chondroblastoma and aneurysmal bone cyst; benign lesions such as osteochondroma, enchondroma, osteoid osteoma, bone cyst, fibrous dysplasia and eosinophilic granuloma; soft tissue sarcomas including liposarcoma, fibrosarcoma and synovial sarcoma; and metastatic bone tumors.